In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OrthoMEMS Inc.

Latest From OrthoMEMS Inc.

The A-List: 2007's Trend Shaping Series A Financings

In 2007, what did Series A venture investments reveal about the state of the health care industry? It was very healthy, thank you. There were quite a few deals to choose from, and numbers demonstrated continued growth in diagnostics fundraising, a resurgence in vaccines, and evidence of pharma's interest in proof-of-concept projects and large-molecule platforms. Medical device investors, meanwhile, remain enamored with concept companies seeking to blend electronics-such as neurostimulation or miniature sensors-with devices.
BioPharmaceutical Medical Device

Ortho Dx: Where Does It Hurt?

Lost in the rush to develop better implants and devices to treat orthopedic injury is the need for better diagnostics capable of pinpointing injury and foretelling the onset of disease. A group of companies is working on just that.
Medical Device

OrthoMEMS: Measuring What Matters in Spine

In spine, measuring the pressure or load on damaged discs can be an important diagnostic, claims OrthoMEMS, every bit as valuable as current diagnostic techniques that look only at anatomical images. Indeed, OrthoeMEMS believes it has hit upon a fundamentally important new diagnostic tool for spine surgeons, one that offers an objective alternative to current subective diagnoses and that could do for spine and orthopedics what blood pressure management did for general medicine or EKGs for cardiology.
Medical Device Innovation

Proteus Biomedical: Using Computers to Manage Chronic Diseases

Modeled after advanced computers used in industrial applications, such as automotives, Proteus Biomedical hopes to bring what it calls pervasive computing to treat chronic conditions such as chronic heart failure and, later on, others. The company's approach combines device and drug therapy in an innovative kind of combination products; in the process, says Proteus, it will define not just a new category of medical products but also shape a new competitive landscape.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Implantable Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • OrthoMEMS Inc.
  • Senior Management
  • Douglas A Lee, Pres. & CEO
    Frank L Lordeman, CFO
  • Contact Info
  • OrthoMEMS Inc.
    1000 Continental Dr.
    Menlo Park, CA 94025